Cite
Effect of Canagliflozin on Heart Failure Hospitalization in Diabetes According to Baseline Heart Failure Risk.
MLA
Khan, Muhammad Shahzeb, et al. “Effect of Canagliflozin on Heart Failure Hospitalization in Diabetes According to Baseline Heart Failure Risk.” JACC. Heart Failure, vol. 11, no. 7, July 2023, pp. 825–35. EBSCOhost, https://doi.org/10.1016/j.jchf.2023.03.025.
APA
Khan, M. S., Segar, M. W., Usman, M. S., Patel, K. V., Van Spall, H. G. C., DeVore, A. D., Vaduganathan, M., Lam, C. S. P., Zannad, F., Verma, S., Butler, J., Tang, W. H. W., & Pandey, A. (2023). Effect of Canagliflozin on Heart Failure Hospitalization in Diabetes According to Baseline Heart Failure Risk. JACC. Heart Failure, 11(7), 825–835. https://doi.org/10.1016/j.jchf.2023.03.025
Chicago
Khan, Muhammad Shahzeb, Matthew W Segar, Muhammad Shariq Usman, Kershaw V Patel, Harriette G C Van Spall, Adam D DeVore, Muthiah Vaduganathan, et al. 2023. “Effect of Canagliflozin on Heart Failure Hospitalization in Diabetes According to Baseline Heart Failure Risk.” JACC. Heart Failure 11 (7): 825–35. doi:10.1016/j.jchf.2023.03.025.